- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Kanamab (Ilaris) is a selective IL-1 β inhibitor primarily used for the treatment of periodic fever syndrome and autoimmune inflammatory diseas...
Pulmozyme is suitable for cystic fibrosis patients and is administered via nebulization. The recommended daily dose is 2.5mg (1 tube) and requi...
Pulmozyme is a nebulized inhalation solution that does not contain tablet components. The standard daily dosage is 2.5mg (1 single dose vial) a...
Anamorelin, as a selective ghrelin receptor agonist, has shown clinical efficacy in improving weight and muscle mass in cancer cachexia patient...
The recommended dosage of Anamorelin is 100mg orally on an empty stomach per day. It is necessary to strictly follow the medication time and sp...
Jaypirca is a non covalent inhibitor targeting BTK, primarily used to treat specific types of B-cell malignancies, including relapsed/refractor...
Pirtobrutinib is a non covalent inhibitor targeting BTK, with a therapeutic focus on specific B-cell malignancies, mainly covering two indicati...
The standard dose of Anamorelin is 100mg orally per day, and the specific number of pills to be taken should be calculated based on the single ...
The recommended usage period of Anamorelin is usually no more than 12 weeks (3 months), mainly used for short-term weight management in cancer ...
The treatment schedule of Adagrasib needs to be personalized based on the treatment response and tolerance of KRAS G12C mutant non-small cell l...
